Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKarolinska University Hospital

About this trial

A biobank within the Swedish national heart failure quality registry SwedeHF.

Eligibility criteria

Qualifiers

Written informed consent

Heart failure defined by symptoms and signs of heart failure as judged by the local investigator

Registered in SwedeHF

Disqualifiers

Plasma donation within 1 month of enrolment or any blood donation/blood loss >500 mL during the 3 months prior to enrolment

Previous allogeneic bone marrow transplant (genetics)

In the opinion of the investigator, condition/s that may either put the patient at risk on participation or influence the results or the patient's ability to participate in the study.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Karolinska University Hospital

Lead sponsor

University Hospital, Linkoeping

Collaborator